Nvidia backs five UK startups, including Cambridge quantum firm Riverlane
What's the deal? Nvidia has invested in five UK startups — Boltz Bio, Foresight Works, Hivergé AIDealroom has a profile for this one. Try Dealroom →, PrimaMenteDealroom has a profile for this one. Try Dealroom →, and Cambridge-based quantum computing firm Riverlane — chief executive Jensen Huang announced at a London event on October 14, 2026. The backing spans AI drug discovery, enterprise AI, and quantum control systems. Specific amounts have not been disclosed.
Why Huang showed up: The chief executive made the announcements in person, lending the occasion executive-level weight that signals strategic intent rather than routine portfolio activity. Nvidia's post framed the breadth simply: "From new medicines to quantum computing, there's plenty to build."
The Riverlane bet: Riverlane is the most forward-looking name on the list. The Cambridge firm builds quantum error-correction software and hardware control systems — the layer that sits between classical computers and quantum processors, and the plumbing quantum machines need before they can do real work. An Nvidia investment here is a hedge on the architecture of computing itself, not near-term revenue.
Why the UK: Britain has spent years positioning itself as Europe's default destination for AI and deep-tech capital. The UK AI Sector Deal of 2018 laid the groundwork with government incentives, talent pipelines, and a regulatory posture built to attract exactly the kind of private investment Nvidia is now deploying.
What's the endgame? For Nvidia, the London push fits a broader European playbook: seeding companies that touch its GPU and software stack so they grow into anchor customers and partners at once. Backing Riverlane signals the company is also watching the horizon beyond current-generation AI hardware.
The signal: One London evening moved five British startups from the margins of the global AI conversation toward its centre — and showed Nvidia extending its ecosystem strategy across Europe's deep-tech capital, from drug design to the frontier of quantum computing.
Read more: nationpress.com
Image credit: IBM Research
